Immunization - Adult Immunization News

 
 
  • 5-Year Safety Data From Upadacitinib Trials Reported Upadacitinib trials in atopic dermatitis have included diverse patient groups with varying risk factors, according to Dr Christopher Bunick.
  • Amoxicillin Short Course Effective for Febrile UTIs Children treated with oral antibiotics for 5 days showed similar UTI recurrence rates at 30 days posttreatment to those who received the standard 10-day course.
  • COVID Strain JN.1 Is Now a 'Variant of Interest,' WHO Says JN.1 was previously grouped with its relative, BA.2.86, but has increased so much in the past 4 weeks that the WHO moved it to standalone status.
  • New $1 Billion Plan for African Vaccine Manufacturing Up to $1 billion will be available to boost African vaccine manufacturing as part of a new scheme set up by Gavi, the Vaccine Alliance, the global health organization said on Thursday.
  • Some Reasons to Get Off the Fence About COVID Booster Though many people remain on the fence about getting the latest COVID vaccine booster, new research suggests a strong argument for getting the shot this winter.
  • Stigma, Regulatory Barriers Delay Mpox Response in DRC Vaccines and treatments that could help tackle an mpox epidemic in the Democratic Republic of Congo are lying unused outside the country despite a high death rate.
  • COVID Vaccines Lower Risk of Serious Illness in Kids Two doses of an mRNA COVID-19 vaccine reduced hospitalizations and emergency department visits by 40%.
  • COVID Vaccines Likely Reversed Premature Birth Trend Researchers suggest this provides further evidence of benefit of SARS-CoV-2 vaccination before or during pregnancy.
  • World at Risk of Losing Malaria Fight as Cases Rise: Report The world is in danger of losing the fight against malaria, as cases of the disease rose by around 5 million year-on-year in 2022, exceeding global targets to contain it, a WHO report showed.
  • WHO Authorizes Emergency Use of Novavax's Updated COVID Shot Novavax's updated vaccine has been granted emergency-use authorization by WHO for active immunization to prevent COVID-19 in individuals aged 12 and older, the company said on Tuesday.
  • ACR 2023 Abatacept Slows Progression to RA, Phase 2b Trial Finds The study was conducted at 28 sites in the United Kingdom and three in the Netherlands.
  • Global Measles Deaths Increased by 43% in 2022 The rise in measles outbreaks and deaths is not surprising, given the recent decline in vaccination rates, said an official of the US Centers for Disease Control and Prevention.
  • EU Regulator Accepts Chikungunya Vaccine Application French drugmaker Valneva said on Monday that the application for its vaccine candidate against mosquito-borne viral disease chikungunya was accepted by the EMA.
  • Extra Messages About HPV Shots Boost Vaccination Rates Children whose parents received a reminder notification that their child was due for vaccination against human papillomavirus were 56% more likely to get the potentially lifesaving shot.
  • Why Don't Doctors Feel Like Heroes Anymore? The 'hero' title can be an inspiring way to honor medical work. But there is a growing belief that while superhuman effort is indeed heroic, superhuman expectations are a systemic problem.
  • Researchers Return to Alzheimer's Vaccines Breakthrough Alzheimer’s treatments that remove toxic proteins from the brain have revived interest in vaccines to treat the memory-robbing disease, potentially offering a cheaper, easy-to-administer option for millions of people, according to interviews with 10 scientists and company executives.
  • 'Staggering' Rise in Measles Cases Last Year: WHO, CDC There was a 'staggering' annual rise in measles cases and deaths in 2022, according to a new report from the World Health Organization and the CDC.
  • Gates Foundation Funds Patch-Style Vaccine Technology The Bill & Melinda Gates Foundation has given $23.6 million to a US-based life science company to fund the first ever mass production of needle-free vaccine technology.
  • AANEM 2023 Sustained Benefit for Newly Approved Myasthenia Gravis Drug Early responders to zilucoplan, the newly approved medication for myasthenia gravis have sustained benefit for up to 60 weeks, new analyses show.
  • ACAAI 2023 Saltwater Gargling May Help Avoid COVID Hospitalization Gargling and nasal rinsing were associated with a significant reduction in the hospitalization rate for people with COVID; if confirmed, the finding could be helpful in low-resource settings, says researcher.
  • 'We Can't Be the Last in Line Again During a Pandemic' The director of the Pan American Health Organization is taking lessons learned from the pandemic to reshape the region's healthcare sector.
  • CDC Says Child Vaccination Exemptions Hit All-Time High The CDC said 3% of children starting kindergarten in the 2022-2023 school year received an exemption from one of the four key vaccines.
  • 'Tripledemic': Your Questions Answered A second flu vaccine? Immunization and the immunocompromised? The CDC's Dr Manisha Patel answers questions from the recent Medscape Masters panel on this year's respiratory virus season.
  • COVID-19 Antivirals Can Trigger Viral Rebound Though antivirals are critical for reducing severe COVID-19 symptoms, researchers suggested that the medication may not always be needed for milder cases.
  • It May Be Time to Pay Attention to COVID Again Since April, a new COVID variant has cropped up. According to recent CDC data, EG.5 — from the Omicron family — now makes up 17% of all cases in the US, up from 7.5% in the first week of July.